$XOMA news
The latest XOMA stock news: headlines, filings, AI summaries and sentiment for $XOMA, updated around the clock.
- Citi Resumes Buy Rating on Ligand Pharmaceuticals Following Acquisition of XOMA Royalty
- XOMA Royalty Corp - 8-K Filing
- XOMA Reports Q4 2025 Earnings with Strong Royalty Growth
- XOMA Reports Q4 2025 Earnings with Strong Royalty Receipts and Portfolio Expansion
- XOMA Royalty Corp - 8-K Filing
- XOMA Royalty Corp - 8-K Filing
- XOMA Royalty Corp - 10-Q Filing
- Ligand (LGND) Q1 2026 Earnings Call Summary
- Ligand Pharmaceuticals Acquires XOMA Royalty for $39/Share, Raises 2026 Guidance
- Ligand Pharmaceuticals Acquires Xoma Royalty for $739 Million
- Ligand Pharmaceuticals to Acquire XOMA Royalty for $39 Per Share
- Ligand Pharmaceuticals to Acquire XOMA Royalty in $740 Million All-Cash Deal